Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
TRN-004
- Development stage
- Preclinical
- Lead developer
- Turn Biotechnologies
- Modality
- mRNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Recombinant Proteins and Enzymes
- Administration
- Ophthalmic
01
Overview
TRN-004 is an investigational ophthalmic therapeutic being developed by Turn Biotechnologies for the rejuvenation of ocular tissues. It is a tailored protein cocktail produced using the proprietary mRNA-based ERA™ (Epigenetic Reprogramming of Aging) platform. The drug is designed to target multiple cell types in the eye, including corneal, limbal, and conjunctival epithelial cells, as well as corneal endothelial cells. By delivering mRNA that encodes specific reprogramming factors, TRN-004 aims to reduce inflammation, oxidative stress, and cellular senescence. It is currently being developed to treat age-related vision conditions and various eye diseases for which no curative treatments are available.
- Other names
- TRN-004TRN004TRN 004
Beyond the preview
Go deeper on TRN-004.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TRN-004.